GUCY2C and Parkinson disease: As multiple epidemiological and experimental studies have implicated altered GI function and a disrupted gut–brain signaling axis in PD pathology, future studies characterizing the impact of GUCY2C on neurodegeneration should not be limited to the role of GUCY2C in the brain.